DUSA Pharmaceuticals, Inc. clinical trials
Acquired by Sun Pharmaceutical Industries Limited, Dec 20, 2012 · source ↗
The registry lists 11 studies whose lead sponsor is DUSA Pharmaceuticals, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 24, 2018.
Before and after it joined Sun Pharmaceutical Industries Limited
- First submitted before DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- 4
- First submitted after DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- 7
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- DUSA Pharmaceuticals, Inc.11 studies
Something wrong with this grouping? Tell us on the Sun Pharmaceutical Industries Limited page.
Studies
Recruiting first, then most recently updated. Showing 11 of 11. All Sun Pharmaceutical Industries Limited studies →
- Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic TherapyCompletedNCT02239679Phase 2
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted after DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on FaceCompletedNCT02632110Phase 2
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted after DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- Phase 3 Study of Levulan With New Blue Light for AK on the Face or ScalpWithdrawnNCT03024060Phase 3
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted after DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)CompletedNCT02628236Phase 2
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted after DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- Maximal Use Systemic Exposure (MUSE) Study of Levulan KerastickCompletedNCT02281136Phase 2
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted after DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)CompletedNCT01475955Phase 2
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted before DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- Twelve Month Follow-Up of CP0108CompletedNCT02209012
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted after DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper ExtremitiesCompletedNCT02137785Phase 3
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted after DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)CompletedNCT01458587Phase 2
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted before DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial AcneCompletedNCT00706433Phase 2
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted before DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited
- ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant RecipientsTerminatedNCT00865878Phase 2
Sponsor listed in the registry: DUSA Pharmaceuticals, Inc. · First submitted before DUSA Pharmaceuticals, Inc. became part of Sun Pharmaceutical Industries Limited